Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741; an Open, Non-Randomised, Single Centre Study in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs ORM 12741 (Primary)
- Indications Schizophrenia
- Focus Pharmacokinetics
- Acronyms ALMAS
- Sponsors Orion
- 13 Mar 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jan 2009 New trial record.